FABP4 and diabetes mellitus: Previous studies using FABP4-deficient mice have demonstrated that FABP4 plays important roles in the development of insulin resistance, diabetes mellitus and atherosclerosis [4–7], and chemical inhibition of FABP4 might be a novel therapeutic agent against insulin resistance, diabetes mellitus and atherosclerosis [8].